The National Association of Specialty Pharmacy (NASP) will host its seventh annual meeting in Washington, DC, on September 9-12, 2019. The gathering is the only comprehensive national specialty pharmacy conference in which all stakeholders can fully participate. It features senior executives, pharmacy directors, staff pharmacists, consultants and other management- level personnel from specialty pharmacy providers, infusion pharmacies, pharma/biotech manufacturers, institutional pharmacies, managed care organizations, GPOs, distributors and suppliers to the industry and covers a wide array of legislative and regulatory policy topics.
“We’re excited to be part of the conference as a sponsor and content contributor,” says Shawn Griffin, president and CEO at URAC. “We welcome these opportunities to partner with other leaders in the field and advance the quality of health care through the rigors of accreditation.”
Heather Bonome, PharmD, and URAC’s director, pharmacy market segment will be speaking on panels regarding managing regulations on September 10 at 9:30am and September 11 at 3:30pm.
“It’s a complicated regulatory landscape we’re in today,” Bonome says. “For example, while there is no law that requires pharmacy accreditation, some payors do mandate it,” she adds. “Accreditation requirements support regulatory compliance by requiring that organizations have a mechanism for tracking, implementing and monitoring compliance with regulations,” she notes.
“I hope to help industry leaders at the conference gain a better understanding of the value of accreditation on a number of levels,” Bonome says. She will be joined on the panels by Brad Howard, attorney with Brown & Fortunato, P.C., and Tim Safley, program director, Accreditation Commission for Health Care (ACHC).
“URAC’s focus on quality principles provides additional rigor that helps to elevate the pharmaceutical practice,” Bonome says. “Educating pharmacists on quality standards can be directly tied to improved outcomes for patients,” she adds.
Bonome will discuss a number of specific challenges in today’s pharmaceutical space, including the care and management of expensive specialty drugs. “Payers want to be sure that these treatments are being used correctly – we use evidence-based protocols to ensure just that,” she says.
“The practice of pharmacy is changing and evolving at seemingly faster speeds day by day,” Bonome says. Licensing does not require something special for specialty drugs. “You need accreditation to demonstrate you are operating at the highest possible level of quality,” Bonome adds.
“Now more than ever, the specialty pharmacy needs to be an integral part of the care team – this is about more than simply licensing a pharmacy,” Bonome notes.
Backed by a 30-year history as an independent, third-party accreditor, URAC is a recognized leader in industry education and innovation.
The organization also announced a new two-day workshop in November to provide the latest details on several important offerings designed to promote pharmacy quality.
URAC’s Pharmacy Quality Management (PQM) Accreditation programs have long been considered the gold standard in pharmacy accreditation. Two of the most recognized programs, Specialty Pharmacy and Mail Service Pharmacy, have recently undergone major revisions, and URAC just launched Version 4.0 for both programs.
In the workshop, URAC clinical leadership, including Ms. Bonome will discuss:
- Why these programs underwent revisions
- The key differences in Version 4.0
- When the new programs will be available
The workshop will occur on November 14 and 15 at the Washington Marriott Georgetown and via livestream.
Register at urac.org/events-webinars.